INmune Bio Inc. Common stock
XNAS:INMB
1.7
$1.75 - 151.00
$1.40 - 4,000.00
$1.62
$1.72
$1.69
$1.7
11.64
1.38
259322
366292.1
22062927.79
Chart
TendieTensor AI Analysis
Company
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.
Fundamentals
13
-0.790000
1.780870
100
BBG00LW94L98
BBG00LW94M14
26.59M
26.59M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own INMB. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.